Detection of Marburg Virus Disease in Guinea

N Engl J Med. 2022 Jun 30;386(26):2528-2530. doi: 10.1056/NEJMc2120183.

Authors

Fara R Koundouno¹, Liana E Kafetzopoulou², Martin Faye³, Annick Renevey¹, Barrè Soropogui⁴, Kékoura Ifono¹, Emily V Nelson¹, Aly A Kamano⁵, Charles Tolno⁶, Giuditta Annibaldis¹, Saa L Millimono¹, Jacob Camara⁴, Karifa Kourouma¹, Ahmadou Doré⁴, Tamba E Millimouno¹, Fernand M B Tolno¹, Julia Hinzmann¹, Hugo Soubrier¹, Mette Hinrichs¹, Anke Thielebein¹, Glaucia Herzer¹, Meike Pahlmann¹, Georges A Ki-Zerbo⁵, Pierre Formenty⁷, Anaïs Legand⁷, Michael R Wiley⁸, Ousmane Faye³, Moussa M Diagne³, Amadou A Sall³, Philippe Lemey², Aïssatou Bah⁴, Stephan Günther¹, Sakoba Keita⁹, Sophie Duraffour¹⁰, N'Faly Magassouba¹¹

Affiliations

¹ Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
² KU Leuven, Leuven, Belgium.
³ Institut Pasteur de Dakar, Dakar, Senegal.
⁴ Université Gamal Abdel Nasser, Conakry, Guinea.
⁵ World Health Organization Guinea, Conakry, Guinea.
⁶ Médecins sans Frontières Belgium, Conakry, Guinea.
⁷ World Health Organization, Geneva, Switzerland.
⁸ University of Nebraska Medical Center, Omaha, NE.
⁹ Agence Nationale de Sécurité Sanitaire, Conakry, Guinea.
¹⁰ Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany duraffour@bnitm.de.
¹¹ Laboratoire des Fièvres Hémorragiques Virales de Guinée, Conakry, Guinea.

No abstract available

Publication types

Letter

MeSH terms

Animals
Antibodies, Viral / isolation & purification
Guinea / epidemiology
Humans
Marburg Virus Disease* / diagnosis
Marburg Virus Disease* / epidemiology
Marburgvirus* / isolation & purification

Substances

Antibodies, Viral

Grants and funding